메뉴 건너뛰기




Volumn 5, Issue 1, 2011, Pages 13-20

A high throughput assay for discovery of bacterial β-glucuronidase inhibitors

Author keywords

glucuronidase; CPT 11; Inhibitor; Screen

Indexed keywords

7 ETHYL 10 HYDROXYCAMPTOTHECIN; BETA GLUCURONIDASE; BETA GLUCURONIDASE INHIBITOR; ENZYME INHIBITOR; HYMECROMONE GLUCURONIDE; IRINOTECAN; UNCLASSIFIED DRUG;

EID: 80053555227     PISSN: None     EISSN: 18753973     Source Type: Journal    
DOI: 10.2174/1875397301105010013     Document Type: Article
Times cited : (25)

References (33)
  • 1
    • 0028896166 scopus 로고
    • Camptothecin and taxol: Discovery to clinic--thirteenth Bruce F. Cain Memorial Award Lecture
    • Wall ME, Wani MC. Camptothecin and taxol: discovery to clinic--thirteenth Bruce F. Cain Memorial Award Lecture. Cancer Res 1995; 55(4): 753-60.
    • (1995) Cancer Res , vol.55 , Issue.4 , pp. 753-760
    • Wall, M.E.1    Wani, M.C.2
  • 2
    • 0022340594 scopus 로고
    • Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I
    • Hsiang YH, Hertzberg R, Hecht S, Liu LF. Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I. J Biol Chem 1985; 260(27): 14873-8.
    • (1985) J Biol Chem , vol.260 , Issue.27 , pp. 14873-14878
    • Hsiang, Y.H.1    Hertzberg, R.2    Hecht, S.3    Liu, L.F.4
  • 3
    • 0032871803 scopus 로고    scopus 로고
    • Structural insights into the function of type IB topoisomerases
    • Redinbo MR, Champoux JJ, Hol WG. Structural insights into the function of type IB topoisomerases. Curr Opin Struct Biol 1999; 9(1): 29-36.
    • (1999) Curr Opin Struct Biol , vol.9 , Issue.1 , pp. 29-36
    • Redinbo, M.R.1    Champoux, J.J.2    Hol, W.G.3
  • 4
    • 0038167666 scopus 로고    scopus 로고
    • The camptothecins
    • Pizzolato JF, Saltz LB. The camptothecins. Lancet. 2003; 361(9376): 2235-42.
    • (2003) Lancet. , vol.361 , Issue.9376 , pp. 2235-2242
    • Pizzolato, J.F.1    Saltz, L.B.2
  • 5
    • 33749034730 scopus 로고    scopus 로고
    • Topoisomerase I inhibitors: Camptothecins and beyond
    • Pommier Y. Topoisomerase I inhibitors: camptothecins and beyond. Nat Rev Cancer 2006; 6(10): 789-802.
    • (2006) Nat Rev Cancer , vol.6 , Issue.10 , pp. 789-802
    • Pommier, Y.1
  • 6
    • 30644464675 scopus 로고    scopus 로고
    • Pharmacogenetics of irinotecan metabolism and transport: An update
    • Smith NF, Figg WD, Sparreboom A. Pharmacogenetics of irinotecan metabolism and transport: an update. Toxicol In vitro 2006; 20(2): 163-75.
    • (2006) Toxicol In vitro , vol.20 , Issue.2 , pp. 163-175
    • Smith, N.F.1    Figg, W.D.2    Sparreboom, A.3
  • 7
    • 0037238805 scopus 로고    scopus 로고
    • Lessons learned from the irinotecan metabolic pathway
    • Ma MK, McLeod HL. Lessons learned from the irinotecan metabolic pathway. Curr Med Chem 2003; 10(1): 41-9.
    • (2003) Curr Med Chem , vol.10 , Issue.1 , pp. 41-49
    • Ma, M.K.1    McLeod, H.L.2
  • 8
    • 0034892379 scopus 로고    scopus 로고
    • Clinical Pharmacokinetics and Metabolism of Irinotecan (CPT-11)
    • Mathijssen RHJ, van Alphen RJ, Verweij J, et al. Clinical Pharmacokinetics and Metabolism of Irinotecan (CPT-11). Clin Cancer Res 2001; 7(8): 2182-94.
    • (2001) Clin Cancer Res , vol.7 , Issue.8 , pp. 2182-2194
    • Mathijssen, R.H.J.1    van Alphen, R.J.2    Verweij, J.3
  • 9
    • 34247618754 scopus 로고    scopus 로고
    • Crystal structure of the cofactor-binding domain of the human phase II drug-metabolism enzyme UDPglucuronosyltransferase 2B7
    • Miley MJ, Zielinska AK, Keenan JE, Bratton SM, Radominska-Pandya A, Redinbo MR. Crystal structure of the cofactor-binding domain of the human phase II drug-metabolism enzyme UDPglucuronosyltransferase 2B7. J Mol Biol 2007; 369(2): 498-511.
    • (2007) J Mol Biol , vol.369 , Issue.2 , pp. 498-511
    • Miley, M.J.1    Zielinska, A.K.2    Keenan, J.E.3    Bratton, S.M.4    Radominska-Pandya, A.5    Redinbo, M.R.6
  • 10
    • 33746780621 scopus 로고    scopus 로고
    • Pharmacogenetics of uridine diphosphoglucuronosyltransferase (UGT) 1A family members and its role in patient response to irinotecan
    • Nagar S, Blanchard RL. Pharmacogenetics of uridine diphosphoglucuronosyltransferase (UGT) 1A family members and its role in patient response to irinotecan. Drug Metab Rev 2006; 38(3): 393-409.
    • (2006) Drug Metab Rev , vol.38 , Issue.3 , pp. 393-409
    • Nagar, S.1    Blanchard, R.L.2
  • 11
    • 77953395957 scopus 로고    scopus 로고
    • Review: Chemotherapy-induced diarrhea: Pathophysiology, frequency and guideline-based management
    • Stein A, Voigt W, Jordan K. Review: Chemotherapy-induced diarrhea: pathophysiology, frequency and guideline-based management. Ther Adv Med Oncol 2010; 2: 51-63.
    • (2010) Ther Adv Med Oncol , vol.2 , pp. 51-63
    • Stein, A.1    Voigt, W.2    Jordan, K.3
  • 12
    • 2642521486 scopus 로고    scopus 로고
    • The relative contributions of carboxylesterase and beta-glucuronidase in the formation of SN-38 in human colorectal tumours
    • Tobin PJ, Dodds HM, Clarke S, Schnitzler M, Rivory LP. The relative contributions of carboxylesterase and beta-glucuronidase in the formation of SN-38 in human colorectal tumours. Oncol rep 2003; 10(6): 1977-9.
    • (2003) Oncol rep , vol.10 , Issue.6 , pp. 1977-1979
    • Tobin, P.J.1    Dodds, H.M.2    Clarke, S.3    Schnitzler, M.4    Rivory, L.P.5
  • 13
    • 33749068024 scopus 로고    scopus 로고
    • St. John's wort attenuates irinotecan-induced diarrhea via down-regulation of intestinal proinflammatory cytokines and inhibition of intestinal epithelial apoptosis
    • Hu ZP, Yang XX, Chan SY, et al. St. John's wort attenuates irinotecan-induced diarrhea via down-regulation of intestinal proinflammatory cytokines and inhibition of intestinal epithelial apoptosis. Toxicol Appl Pharmacol 2006; 216(2): 225-37.
    • (2006) Toxicol Appl Pharmacol , vol.216 , Issue.2 , pp. 225-237
    • Hu, Z.P.1    Yang, X.X.2    Chan, S.Y.3
  • 14
    • 78651061453 scopus 로고    scopus 로고
    • Streptomycin alleviates irinotecan-induced delayed-onset diarrhea in rats by a mechanism other than inhibition of beta-glucuronidase activity in intestinal lumen
    • Kurita A, Kado S, Matsumoto T, et al. Streptomycin alleviates irinotecan-induced delayed-onset diarrhea in rats by a mechanism other than inhibition of beta-glucuronidase activity in intestinal lumen. Cancer Chemother Pharmacol 2011; 67(1): 201-13.
    • (2011) Cancer Chemother Pharmacol , vol.67 , Issue.1 , pp. 201-213
    • Kurita, A.1    Kado, S.2    Matsumoto, T.3
  • 15
    • 37049006270 scopus 로고    scopus 로고
    • Phase II clinical trial for prevention of delayed diarrhea with cholestyramine/levofloxacin in the second-line treatment with irinotecan biweekly in patients with metastatic colorectal carcinoma
    • Flieger D, Klassert C, Hainke S, Keller R, Kleinschmidt R, Fischbach W. Phase II clinical trial for prevention of delayed diarrhea with cholestyramine/levofloxacin in the second-line treatment with irinotecan biweekly in patients with metastatic colorectal carcinoma. Oncology 2007; 72(1-2): 10-6.
    • (2007) Oncology , vol.72 , Issue.1-2 , pp. 10-16
    • Flieger, D.1    Klassert, C.2    Hainke, S.3    Keller, R.4    Kleinschmidt, R.5    Fischbach, W.6
  • 16
    • 0031262639 scopus 로고    scopus 로고
    • Role of intestinal bacteria in nutrient metabolism
    • Cummings JH, Macfarlane GT. Role of intestinal bacteria in nutrient metabolism. J Parenter Enteral Nutr 1997; 21(6): 357-65.
    • (1997) J Parenter Enteral Nutr , vol.21 , Issue.6 , pp. 357-365
    • Cummings, J.H.1    McFarlane, G.T.2
  • 17
    • 0037425743 scopus 로고    scopus 로고
    • Gut flora in health and disease
    • Guarner F, Malagelada JR. Gut flora in health and disease. Lancet 2003; 361: 512-9.
    • (2003) Lancet , vol.361 , pp. 512-519
    • Guarner, F.1    Malagelada, J.R.2
  • 18
    • 77951026738 scopus 로고    scopus 로고
    • Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA)
    • Cohen SH, Gerding DN, Johnson S, et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect Control Hosp Epidemiol 2010; 31(5): 431-55.
    • (2010) Infect Control Hosp Epidemiol , vol.31 , Issue.5 , pp. 431-455
    • Cohen, S.H.1    Gerding, D.N.2    Johnson, S.3
  • 19
    • 10944272743 scopus 로고    scopus 로고
    • Antibacterial resistance worldwide: Causes, challenges and responses
    • Levy SB, Marshall B. Antibacterial resistance worldwide: causes, challenges and responses. Nat Med 2004; 10(12 Suppl): S122-9.
    • (2004) Nat Med , vol.10 , Issue.12 SUPPL
    • Levy, S.B.1    Marshall, B.2
  • 20
    • 0021337428 scopus 로고
    • Impact of antimicrobial agents on the gastrointestinal microflora and the risk of infections
    • Nord CE, Kager L, Heimdahl A. Impact of antimicrobial agents on the gastrointestinal microflora and the risk of infections. Am J Med 1984; 76(5A): 99-106.
    • (1984) Am J Med , vol.76 , Issue.5 A , pp. 99-106
    • Nord, C.E.1    Kager, L.2    Heimdahl, A.3
  • 21
    • 0032730770 scopus 로고    scopus 로고
    • Irinotecan (CPT-11) induced colitis: Report of a case and review of Food and Drug Administration MEDWATCH reporting
    • Sears S, McNally P, Bachinski MS, Avery R. Irinotecan (CPT-11) induced colitis: report of a case and review of Food and Drug Administration MEDWATCH reporting. Gastrointest Endosc 1999; 50(6): 841-4.
    • (1999) Gastrointest Endosc , vol.50 , Issue.6 , pp. 841-844
    • Sears, S.1    McNally, P.2    Bachinski, M.S.3    Avery, R.4
  • 22
    • 0029823366 scopus 로고    scopus 로고
    • Review article: Antibiotic-induced Clostridium difficile infection
    • Settle CD, Wilcox MH. Review article: antibiotic-induced Clostridium difficile infection. Alim Pharmacol Ther 1996; 10(6): 835-41.
    • (1996) Alim Pharmacol Ther , vol.10 , Issue.6 , pp. 835-841
    • Settle, C.D.1    Wilcox, M.H.2
  • 23
    • 3342986585 scopus 로고    scopus 로고
    • Antibiotic therapy may induce cancers in the colon and breasts through a mechanism involving bile acids and colonic bacteria
    • Stamp D. Antibiotic therapy may induce cancers in the colon and breasts through a mechanism involving bile acids and colonic bacteria. Med Hypotheses 2004; 63(3): 555-6.
    • (2004) Med Hypotheses , vol.63 , Issue.3 , pp. 555-556
    • Stamp, D.1
  • 24
    • 33751361302 scopus 로고    scopus 로고
    • Bacteria, inflammation, and colon cancer
    • Yang L, Pei Z. Bacteria, inflammation, and colon cancer. World J Gastroenterol 2006; 12(42): 6741-6.
    • (2006) World J Gastroenterol , vol.12 , Issue.42 , pp. 6741-6746
    • Yang, L.1    Pei, Z.2
  • 26
    • 0036135758 scopus 로고    scopus 로고
    • Hydrolysis of 4-methylumbelliferyl-beta-D-glucuronide in differing sample fractions of river waters and its implication for the detection of fecal pollution
    • Farnleitner AH, Hocke L, Beiwl C, Kavka GC, Mach RL. Hydrolysis of 4-methylumbelliferyl-beta-D-glucuronide in differing sample fractions of river waters and its implication for the detection of fecal pollution. Water Res 2002; 36: 975-81.
    • (2002) Water Res , vol.36 , pp. 975-981
    • Farnleitner, A.H.1    Hocke, L.2    Beiwl, C.3    Kavka, G.C.4    Mach, R.L.5
  • 28
    • 0035287418 scopus 로고    scopus 로고
    • Identification and cloning of gusA, encoding a new beta-glucuronidase from Lactobacillus gasseri ADH
    • Russell WM, Klaenhammer TR. Identification and cloning of gusA, encoding a new beta-glucuronidase from Lactobacillus gasseri ADH. Appl Environ Microbiol 2001; 67(3): 1253-61.
    • (2001) Appl Environ Microbiol , vol.67 , Issue.3 , pp. 1253-1261
    • Russell, W.M.1    Klaenhammer, T.R.2
  • 29
    • 78149295964 scopus 로고    scopus 로고
    • Alleviating cancer drug toxicity by inhibiting a bacterial enzyme
    • Wallace BD, Wang H, Lane KT, et al. Alleviating cancer drug toxicity by inhibiting a bacterial enzyme. Science 2010; 330(6005): 831-5.
    • (2010) Science , vol.330 , Issue.6005 , pp. 831-835
    • Wallace, B.D.1    Wang, H.2    Lane, K.T.3
  • 30
    • 0033003760 scopus 로고    scopus 로고
    • A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays
    • Zhang JH, Chung TD, Oldenburg KR. A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays. J Biomol Screen 1999; 4(2): 67-73.
    • (1999) J Biomol Screen , vol.4 , Issue.2 , pp. 67-73
    • Zhang, J.H.1    Chung, T.D.2    Oldenburg, K.R.3
  • 31
    • 0015368548 scopus 로고
    • A new potent-glucuronidase inhibitor, D-glucaro--lactam derived from nojirimycin
    • Niwa T, Tsuruoka T, Inoue S, Naito Y, Koeda T. A new potent-glucuronidase inhibitor, D-glucaro--lactam derived from nojirimycin. J Biochem 1972; 72(1): 207-11.
    • (1972) J Biochem , vol.72 , Issue.1 , pp. 207-211
    • Niwa, T.1    Tsuruoka, T.2    Inoue, S.3    Naito, Y.4    Koeda, T.5
  • 32
    • 34249000046 scopus 로고    scopus 로고
    • A high-throughput screen for aggregation-based inhibition in a large compound library
    • Feng BY, Simeonov A, Jadhav A, Babaoglu K, Inglese J, Shoichet BK, et al. A high-throughput screen for aggregation-based inhibition in a large compound library. J Med Chem 2007; 50(10): 2385-90.
    • (2007) J Med Chem , vol.50 , Issue.10 , pp. 2385-2390
    • Feng, B.Y.1    Simeonov, A.2    Jadhav, A.3    Babaoglu, K.4    Inglese, J.5    Shoichet, B.K.6
  • 33
    • 0037061628 scopus 로고    scopus 로고
    • A common mechanism underlying promiscuous inhibitors from virtual and high-throughput screening
    • McGovern SL, Caselli E, Grigorieff N, Shoichet BK. A common mechanism underlying promiscuous inhibitors from virtual and high-throughput screening. J Med Chem 2002; 45(8): 1712-22.
    • (2002) J Med Chem , vol.45 , Issue.8 , pp. 1712-1722
    • McGovern, S.L.1    Caselli, E.2    Grigorieff, N.3    Shoichet, B.K.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.